{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:21:08Z","timestamp":1761740468907,"version":"3.40.3"},"reference-count":117,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Atheroscler Rep"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1007\/s11883-006-0049-1","type":"journal-article","created":{"date-parts":[[2007,6,5]],"date-time":"2007-06-05T11:59:02Z","timestamp":1181044742000},"page":"119-130","source":"Crossref","is-referenced-by-count":23,"title":["Cardiac allograft vasculopathy: The achilles\u2019 heel of long-term survival after cardiac transplantation"],"prefix":"10.1007","volume":"8","author":[{"given":"Amandeep","family":"Dhaliwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Thohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"49_CR1","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1001\/jama.258.21.3142","volume":"258","author":"JS Schroeder","year":"1987","unstructured":"Schroeder JS, Hunt S: Cardiac transplantation. Update 1987. JAMA 1987, 258:2142\u20132155.","journal-title":"JAMA"},{"key":"49_CR2","unstructured":"United Network for Organ Sharing: http:\/\/www.unos.org. Accessed November 15, 2005."},{"key":"49_CR3","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","volume":"349","author":"HJ Eisen","year":"2003","unstructured":"Eisen HJ, Tuzcu EM, Dorent R, et al.: Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 2003, 349:847\u2013858.","journal-title":"N Engl J Med"},{"key":"49_CR4","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.healun.2005.05.019","volume":"24","author":"EP Trulock","year":"2005","unstructured":"Trulock EP, Edwards LB, Taylor DO, et al.: Registry of the International Society for Heart and Lung Transplantation: Twenty-second Official Adult Lung and Heart-Lung Transplant Report\u20142005. J Heart Lung Transplant 2005, 24:956\u2013967.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.41.5.753","volume":"41","author":"CP Bieber","year":"1970","unstructured":"Bieber CP, Stinson EB, Shumway NE, et al.: Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation 1970, 41:753\u2013772.","journal-title":"Circulation"},{"issue":"Suppl 3","key":"49_CR6","first-page":"100","volume":"80","author":"SZ Gao","year":"1989","unstructured":"Gao SZ, Schroeder JS, Alderman EL, et al.: Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens. Circulation 1989, 80(Suppl 3):100\u2013105.","journal-title":"Circulation"},{"key":"49_CR7","first-page":"111","volume":"80","author":"MT Olivari","year":"1989","unstructured":"Olivari MT, Homans DC, Wilson RF, et al.: Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy. Circulation 1989, 80:111\u2013115.","journal-title":"Circulation"},{"key":"49_CR8","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.CIR.76.4.827","volume":"76","author":"BF Uretsky","year":"1987","unstructured":"Uretsky BF, Murali S, Reddy PS, et al.: Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987, 76:827\u2013834.","journal-title":"Circulation"},{"key":"49_CR9","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/S0022-5223(95)70191-5","volume":"109","author":"DC McGiffin","year":"1995","unstructured":"McGiffin DC, Savunen T, Kirklin JK, et al.: Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events. J Thorac Cardiovasc Surg 1995, 109:1081\u20131088.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"49_CR10","first-page":"S215","volume":"14","author":"AC Yeung","year":"1995","unstructured":"Yeung AC, Davis SF, Hauptmann PJ, et al.: Incidence and progression of transplant coronary artery disease over I year: results of a multicenter trial with use of intravascular ultrasound. J Heart Lung Transplant 1995, 14:S215-S220.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR11","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0735-1097(94)00323-I","volume":"25","author":"PR Rickenbacher","year":"1995","unstructured":"Rickenbacher PR, Pinto FJ, Chenzbraun A, et al.: Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995, 25:171\u2013177.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR12","first-page":"892","volume":"11","author":"AM Keogh","year":"1992","unstructured":"Keogh AM, Valantine HA, Hunt SA, et al.: Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant 1992, 11:892\u2013901.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR13","first-page":"S45","volume":"11","author":"BF Uretsky","year":"1992","unstructured":"Uretsky BF, Kormos RL, Zerbe TR, et al.: Cardiac events after transplantation: incidence and predictive value of coronary arteriopathy. J Heart Lung Transplant 1992, 11:S45-S51.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR14","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/0735-1097(96)00201-X","volume":"28","author":"SZ Gao","year":"1996","unstructured":"Gao SZ, Hunt SA, Schroeder JS, et al.: Early development of accelerated graft coronary artery disease: risk factors and course. J Am Coll Cardiol 1996, 28:673\u2013679.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR15","first-page":"191","volume":"70","author":"JD Alexis","year":"2003","unstructured":"Alexis JD, Pyo RT, Chereshnev I: Immunologic factors in transplant arteriopathy. Mt Sinai J Med 2003, 70:191\u2013196.","journal-title":"Mt Sinai J Med"},{"key":"49_CR16","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S1053-2498(00)00125-X","volume":"19","author":"CM Balantyne","year":"2000","unstructured":"Balantyne CM: Statins after cardiac transplantation: which statin, what dose and how low should we go?\n                           J Heart Lung Transplant 2000, 19:515\u2013517.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR17","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.CIR.98.24.2672","volume":"98","author":"SR Kapadia","year":"1998","unstructured":"Kapadia SR, Nissen SE, Ziada KM, et al.: Development of transplantation vasculopathy and progression of donor-transmitted atherosclerosis: comparison by serial intravascular ultrasound imaging. Circulation 1998, 98:2672\u20132678.","journal-title":"Circulation"},{"key":"49_CR18","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S1053-2498(00)00249-7","volume":"20","author":"J Jimenez","year":"2001","unstructured":"Jimenez J, Kapadia SR, Yamani MH, et al.: Cellular rejection and rate of progression of transplant vasculopathy: A 3-year serial intravascular ultrasound study. J Heart Lung Transplant 2001, 20:393\u2013398.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR19","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/S0140-6736(02)08154-0","volume":"359","author":"JC Fang","year":"2002","unstructured":"Fang JC, Kinlay S, Beltrame J, et al.: Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial. Lancet 2002, 359:1108\u20131113.","journal-title":"Lancet"},{"issue":"11 Suppl 1","key":"49_CR20","first-page":"II200","volume":"110","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Mokhtari GK, Terry RD, et al.: Overexpression of human copper\/zinc superoxide dismutase (SOD1) suppresses ischemia-reperfusion injury and subsequent development of graft coronary artery disease in murine cardiac grafts. Circulation 2004, 110(11 Suppl 1):II200-II206.","journal-title":"Circulation"},{"key":"49_CR21","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1097\/01.TP.0000137321.34200.FA","volume":"78","author":"S Murata","year":"2004","unstructured":"Murata S, Miniati DN, Kown MH, et al.: Superoxide dismutase mimetic m40401 reduces ischemia-reperfusion injury and graft coronary artery disease in rodent cardiac allografts. Transplantation 2004, 78:1166\u20131171.","journal-title":"Transplantation"},{"key":"49_CR22","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1161\/01.CIR.0000015606.69079.27","volume":"105","author":"C Ferri","year":"2002","unstructured":"Ferri C, Properzi G, Tomassoni G, et al.: Patterns of myocardial endothelin-1 expression and outcome after cardiac transplantation. Circulation 2002, 105:1768\u20131771.","journal-title":"Circulation"},{"key":"49_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/00001573-200103000-00006","volume":"16","author":"CA Laberrere","year":"2001","unstructured":"Laberrere CA, Nelson DR, Park JW: Pathologic markers of allograft vasculopathy: insight into the pathophysiology of allograft chronic rejection. Curr Opin Cardiol 2001, 16:110\u2013117.","journal-title":"Curr Opin Cardiol"},{"key":"49_CR24","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1001\/jama.284.4.457","volume":"284","author":"CA Labarrere","year":"2000","unstructured":"Labarrere CA, Nelson DR, Cox CJ, et al.: Cardiac-specific troponin I levels and risk of coronary artery disease and graft failure following heart transplantation. JAMA 2000, 284:457\u2013464.","journal-title":"JAMA"},{"key":"49_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1056\/NEJM199510263331704","volume":"333","author":"CA Laberrere","year":"1995","unstructured":"Laberrere CA, Pitts D, Nelson DR, Faulk WP: Vascular tissue plasminogen activator and the development of coronary artery disease in heart transplant recipients. N Engl J Med 1995, 333:1111\u20131116.","journal-title":"N Engl J Med"},{"key":"49_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0008-6363(97)00088-6","volume":"35","author":"MR Garvin","year":"1997","unstructured":"Garvin MR, Labinaz M, Pels K, et al.: Arterial expression of the plasminogen activator system early after cardiac transplantation. Cardiovasc Res 1997, 35:241\u2013249.","journal-title":"Cardiovasc Res"},{"key":"49_CR27","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S1053-2498(00)00230-8","volume":"20","author":"CK Wong","year":"2001","unstructured":"Wong CK, Ganz P, Miller L, et al.: Role of vascular remodeling in the pathogenesis of early transplant coronary artery disease: a multicenter prospective ultrasound study. J Heart Lung Transplant 2001, 20:385\u2013392.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/01.CIR.95.4.885","volume":"95","author":"TT Lim","year":"1997","unstructured":"Lim TT, Liang DH, Botas J, et al.: Role of compensatory enlargement and shrinkage in transplant coronary artery disease: serial intravascular ultrasound study. Circulation 1997, 95:885\u2013859.","journal-title":"Circulation"},{"key":"49_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0735-1097(99)00159-X","volume":"34","author":"K Pethig","year":"1999","unstructured":"Pethig K, Heublein B, Meliss RR, et al.: Volumetric remodeling of the proximal left coronary artery: early versus late after heart transplantation. J Am Coll Cardiol 1999, 34:197\u2013203.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/hc3101.093867","volume":"104","author":"H Tsutsui","year":"2001","unstructured":"Tsutsui H, Ziada KM, Schoenhagen P, et al.: Lumen loss in transplant coronary artery disease is a biphasic process involving early intimal thickening and late constrictive remodeling: results from a 5 year serial intravascular ultrasound study. Circulation 2001, 104:653\u2013657.","journal-title":"Circulation"},{"key":"49_CR31","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0195-668X(03)00237-9","volume":"24","author":"G Vassalli","year":"2003","unstructured":"Vassalli G, Gallino A, Weis M, von Scheidt W, et al.: Alloimmunity and nonimmunologic risk factors in cardiac allograft vasculopathy. Eur Heart J 2003, 24:1180\u20131188.","journal-title":"Eur Heart J"},{"key":"49_CR32","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/j.1600-6143.2004.00434.x","volume":"4","author":"AL Caforio","year":"2004","unstructured":"Caforio AL, Tona F, Fortina AB, et al.: Immune and nonimmune predictors of cardiac allograft vasculopathy onset and severity: multivariate risk factor analysis and role of immunosuppression. Am J Transplantation 2004, 4:962\u2013970.","journal-title":"Am J Transplantation"},{"key":"49_CR33","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1097\/01.TP.0000054929.87347.59","volume":"75","author":"J Vamvakopoulos","year":"2003","unstructured":"Vamvakopoulos J, Hayry P: Cytomegalovirus and transplant arteriopathy: evidence for a link is mounting but the jury is still out. Transplantation 2003, 75:742\u2013743.","journal-title":"Transplantation"},{"key":"49_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1056\/NEJM199403243301203","volume":"330","author":"G Opelz","year":"1994","unstructured":"Opelz G, Wujciak T: The influence of HLA compatibility on graft survival. Collaborative Transplant Study. N Engl J Med 1994, 330:816\u2013819.","journal-title":"N Engl J Med"},{"key":"49_CR35","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0002-9149(99)00487-7","volume":"8","author":"L Gullestad","year":"1999","unstructured":"Gullestad L, Simonsen S, Ueland T, et al.: Possible role of proinflammatory cytokines in heart allograft coronary artery disease. Am J Cardiol 1999, 8:999\u20131003.","journal-title":"Am J Cardiol"},{"key":"49_CR36","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1161\/01.CIR.102.13.1549","volume":"102","author":"CA Labarrere","year":"2000","unstructured":"Labarrere CA, Nelson DR, Miller SJ, et al.: Value of serum-soluble intercellular adhesion molecule-1 for the noninvasive risk assessment of transplant coronary artery disease, posttransplant ischemic events, and cardiac graft failure. Circulation 2000, 102:1549\u20131555.","journal-title":"Circulation"},{"key":"49_CR37","first-page":"597","volume":"13","author":"CM Ballantyne","year":"1994","unstructured":"Ballantyne CM, Mainolfi EA, Young JB, et al.: Relationship of increased levels of circulating intercellular adhesion molecule 1 after heart transplantation to rejection: human leukocyte antigen mismatch and survival. J Heart Lung Transplant 1994, 13:597\u2013603.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.trim.2003.08.002","volume":"12","author":"ER Vasilescu","year":"2004","unstructured":"Vasilescu ER, Ho EK, de la Torre L, et al.: Anti-HLA antibodies in heart transplantation. Transplant Immunol 2004, 12:177\u2013183.","journal-title":"Transplant Immunol"},{"key":"49_CR39","first-page":"III122","volume":"80","author":"GA Petrossian","year":"1989","unstructured":"Petrossian GA, Nichols AB, Marboe CC, et al.: Relationship between survival and development of coronary artery disease and anti-HLA antibodies after Cardiac Transplantation. Circulation 1989, 80:III122-III125.","journal-title":"Circulation"},{"key":"49_CR40","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00007890-199602270-00009","volume":"61","author":"EF Reed","year":"1996","unstructured":"Reed EF, Hong B, Ho E, et al.: Monitoring of soluble HLA allo-antigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation 1996, 61:566\u2013572.","journal-title":"Transplantation"},{"key":"49_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/S1053-2498(02)00472-2","volume":"22","author":"PJ Michaels","year":"2003","unstructured":"Michaels PJ, Espejo ML, Kobashigawa J, et al.: Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 2003, 22:58\u201369.","journal-title":"J Heart Lung Transplant"},{"issue":"Suppl 9","key":"49_CR42","first-page":"IX\/11","volume":"89","author":"ML Rose","year":"2000","unstructured":"Rose ML: Role of antibodies in transplant-associated cardiac allograft vasculopathy. Z Kardiol 2000, 89(Suppl 9):IX\/11-IX15.","journal-title":"Z Kardiol"},{"key":"49_CR43","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/00007890-200104150-00011","volume":"71","author":"S Jurcevic","year":"2001","unstructured":"Jurcevic S, Ainsworth ME, Pomerance A, et al.: Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001, 71:886\u2013892.","journal-title":"Transplantation"},{"key":"49_CR44","first-page":"439","volume":"1","author":"AD Collins","year":"1998","unstructured":"Collins AD, Ationu A: The role of anti-endothelial antibodies in the immunopathogenesis of transplant associated coronary artery disease. Int J Mol Med 1998, 1:439\u2013452.","journal-title":"Int J Mol Med"},{"key":"49_CR45","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S0198-8859(99)00056-7","volume":"60","author":"WP Faulk","year":"1999","unstructured":"Faulk WP, Rose M, Meroni PL, et al.: Antibodies to endothelial cells identify myocardial damage and predict development of coronary artery disease in patients with transplanted hearts. Hum Immunol 1999, 60:826\u2013832.","journal-title":"Hum Immunol"},{"key":"49_CR46","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1001\/jama.261.24.3561","volume":"261","author":"MT Grattan","year":"1989","unstructured":"Grattan MT, Moreno-Cabral CE, Starnes VA, et al.: Cytomegalovirus infection is associated with cardiac allograft rejection and artherosclerosis. JAMA 1989, 261:3561.","journal-title":"JAMA"},{"key":"49_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/01.TP.0000054231.42217.A5","volume":"75","author":"L Potena","year":"2003","unstructured":"Potena L, Grigioni F, Ortolani P, et al.: Relevance of cytomegalovirus infection and coronary-artery remodeling in the first year after heart transplantation: a prospective three-dimensional intravascular ultrasound study. Transplantation 2003, 75:839\u2013843.","journal-title":"Transplantation"},{"issue":"11 Suppl 1","key":"49_CR48","first-page":"II207","volume":"110","author":"P Petrakopoulou","year":"2004","unstructured":"Petrakopoulou P, Kubrich M, Pehlivanli S, et al.: Cytomegalovirus infection in heart transplant recipients is associated with impaired endothelial function. Circulation 2004, 110(11 Suppl 1):II207-II212.","journal-title":"Circulation"},{"key":"49_CR49","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/01.CIR.0000109692.16004.AF","volume":"109","author":"M Weis","year":"2004","unstructured":"Weis M, Kledal TN, Lin KY, et al.: Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis. Circulation 2004, 109:500\u2013505.","journal-title":"Circulation"},{"key":"49_CR50","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1056\/NEJM200105173442002","volume":"244","author":"GS Shirali","year":"2001","unstructured":"Shirali GS, Ni J, Chinnock RE, et al.: Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 2001, 244:1498\u20131503.","journal-title":"N Engl J Med"},{"key":"49_CR51","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ijcard.2003.05.027","volume":"95","author":"M Yousufuddin","year":"2004","unstructured":"Yousufuddin M, Yamani MH: The renin-angiotensin hypothesis for the pathogenesis of cardiac allograft vasculopathy. Int J Cardiol 2004, 95:123\u2013127.","journal-title":"Int J Cardiol"},{"key":"49_CR52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1432-2277.2003.tb00219.x","volume":"16","author":"MH Richter","year":"2003","unstructured":"Richter MH, Richter HR, Olbrich HG, et al.: Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy. Transplant Int 2003, 16:26\u201332.","journal-title":"Transplant Int"},{"key":"49_CR53","first-page":"286","volume":"88","author":"J Kobayashi","year":"1993","unstructured":"Kobayashi J, Crawford S, Backer CL, et al.: Captopril reduces graft coronary artery disease in a rat heterotropic transplant model. Circulation 1993, 88:286\u2013290.","journal-title":"Circulation"},{"key":"49_CR54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/01.CIR.93.2.333","volume":"93","author":"Y Furukawa","year":"1996","unstructured":"Furukawa Y, Matsumori A, Hirozane T, et al.: Angiotensin II receptor antagonist TCV-116 reduces graft coronary artery disease and preserve graft status in murine model. A comparative study with captopril. Circulation 1996, 93:333\u2013339.","journal-title":"Circulation"},{"key":"49_CR55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.healun.2003.07.010","volume":"23","author":"SE Crawford","year":"2004","unstructured":"Crawford SE, Mavroudis C, Backer CL, et al.: Captopril suppresses post-transplantation angiogenic activity in rat allograft coronary vessels. J Heart Lung Transplant 2004, 23:666\u2013673.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR56","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0735-1097(03)00646-6","volume":"42","author":"HO Ventura","year":"2003","unstructured":"Ventura HO, Mehra MR: C-Reactive protein and cardiac allograft vasculopathy. Is inflammation the critical link?\n                           J Am Coll Cardiol 2003, 42:483\u2013485.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR57","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S0735-1097(03)00645-4","volume":"42","author":"A Hognestad","year":"2003","unstructured":"Hognestad A, Endresen K, Wergeland R, et al.: Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients. J Am Coll Cardiol 2003, 42:477\u2013482.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR58","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1016\/S0140-6736(02)11473-5","volume":"360","author":"CA Labarrere","year":"2002","unstructured":"Labarrere CA, Lee JB, Nelson DR, et al.: C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 2002, 360:1462\u20131467.","journal-title":"Lancet"},{"key":"49_CR59","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1161\/01.CIR.0000096055.62724.C5","volume":"108","author":"P Calabro","year":"2003","unstructured":"Calabro P, Willerson JT, Yeh ET: Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 2003, 108:1930\u20131932.","journal-title":"Circulation"},{"key":"49_CR60","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1161\/hc5001.100796","volume":"104","author":"SM Hollenberg","year":"2001","unstructured":"Hollenberg SM, Klein LW, Parrillo JE, et al.: Coronary endothelial dysfunction after heart transplantation predicts allograft vasculopathy and cardiac death. Circulation 2001, 104:3091\u20133096.","journal-title":"Circulation"},{"key":"49_CR61","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/00007890-200112270-00004","volume":"72","author":"E Andriambeloson","year":"2001","unstructured":"Andriambeloson E, Pally C, Hengerer B, et al.: Transplantation-induced endothelial dysfunction as studied in rat aorta allografts. Transplantation 2001, 72:1881\u20131889.","journal-title":"Transplantation"},{"key":"49_CR62","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S1053-2498(03)00150-5","volume":"23","author":"SM Hollenberg","year":"2004","unstructured":"Hollenberg SM, Klein LW, Parrillo JE, et al.: Changes in coronary endothelial function predict progression of allograft vasculopathy after heart transplantation. J Heart Lung Transplant 2004, 23:265\u2013271.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR63","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/01.CIR.93.3.457","volume":"93","author":"SF Davis","year":"1996","unstructured":"Davis SF, Yeung AC, Meredith IT, et al.: Early endothelial dysfunction predicts the development of transplant coronary artery disease at 1 year posttransplant. Circulation 1996, 93:457\u2013462.","journal-title":"Circulation"},{"key":"49_CR64","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1001\/jama.278.14.1169","volume":"278","author":"CA Labarrere","year":"1997","unstructured":"Labarrere CA, Nelson DR, Faulk WP: Endothelial activation and development of coronary artery disease in transplanted human hearts. JAMA 1997, 278:1169\u20131175.","journal-title":"JAMA"},{"key":"49_CR65","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1097\/01.TP.0000137930.40597.03","volume":"78","author":"H Methe","year":"2004","unstructured":"Methe H, Zimmer E, Grimm R, et al.: Evidence for a role of toll-like receptor 4 in development of chronic allograft rejection after cardiac transplantation. Transplantation 2004, 78:1324\u20131331.","journal-title":"Transplantation"},{"key":"49_CR66","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1073\/pnas.93.9.4051","volume":"93","author":"C Shi","year":"1996","unstructured":"Shi C, Lee WS, He Q, Zhang D, et al.: Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci U S A 1996, 93:4051\u20134056.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"49_CR67","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1172\/JCI4584","volume":"103","author":"C Shi","year":"1999","unstructured":"Shi C, Feinberg MW, Zhang D, et al.: Donor MHC and adhesion molecules in transplant arteriosclerosis. J Clin Invest 1999, 103:469\u2013474.","journal-title":"J Clin Invest"},{"key":"49_CR68","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/01.ATV.20.2.343","volume":"20","author":"H Dietrich","year":"2000","unstructured":"Dietrich H, Hu Y, Zou Y, et al.: Mouse model of transplant arteriosclerosis: role of intercellular adhesion molecule-1. Arterioscler Thromb Vasc Biol 2000, 20:343\u2013352.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"49_CR69","first-page":"359","volume":"152","author":"A Raisanen-Sokolowski","year":"1998","unstructured":"Raisanen-Sokolowski A, Glysing-Jensen T, Koglin J, et al.: Reduced transplant arterioscleross in murine cardiac allografts placed in interferon gamma knockout recipients. Am J Pathol 1998, 152:359\u2013365.","journal-title":"Am J Pathol"},{"key":"49_CR70","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/01.CIR.101.9.1034","volume":"101","author":"J Koglin","year":"2000","unstructured":"Koglin J, Glysing-Jensen T, Gadiraju S, et al.: Attenuated cardiac allograft vasculopathy in mice with targeted depletion of transcription factor stat 4. Circulation 2000, 101:1034\u20131039.","journal-title":"Circulation"},{"key":"49_CR71","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1172\/JCI8126","volume":"105","author":"W Gao","year":"2000","unstructured":"Gao W, Topham PS, King JA, et al.: Targeting of the chemokine receptor CCR 1 suppresses the development of acute and chronic cardiac allograft rejection. J Clin Invest 2000, 105:35\u201344.","journal-title":"J Clin Invest"},{"key":"49_CR72","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/00007890-200110150-00003","volume":"72","author":"W Gao","year":"2001","unstructured":"Gao W, Faia KL, Csizmadia V, et al.: Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 2001, 72:1199\u20131205.","journal-title":"Transplantation"},{"key":"49_CR73","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0002-9440(10)65737-9","volume":"153","author":"Raisanen-Sokolowski","year":"1998","unstructured":"Raisanen-Sokolowski, Glysing-Jensen T, Russel ME: Leukocyte suppressing influences of interleukin 10 in cardiac allografts: insights from IL-10 knockout mice. Am J Pathol 1998, 153:1491\u20131500.","journal-title":"Am J Pathol"},{"issue":"11 Suppl 1","key":"49_CR74","first-page":"II194","volume":"110","author":"M Tanaka","year":"2004","unstructured":"Tanaka M, Terry RD, Mokhtari GK, et al.: Suppression of graft coronary artery disease by a brief treatment with a selective epsilonPKC activator and a deltaPKC inhibitor in murine cardiac allografts. Circulation 2004, 110(11 Suppl 1):II194-II199.","journal-title":"Circulation"},{"key":"49_CR75","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/0002-9149(93)91066-Q","volume":"72","author":"HO Ventura","year":"1993","unstructured":"Ventura HO, White CJ, Jain SP, et al.: Assessment of intracoronary morphology in cardiac transplant recipients by angioscopy and intravascular ultrasound. Am J Cardiol 1993, 72:805\u2013809.","journal-title":"Am J Cardiol"},{"key":"49_CR76","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/01.CIR.85.3.979","volume":"85","author":"FG St Goar","year":"1992","unstructured":"St Goar FG, Pinto FJ, Alderman EL, et al.: Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of \u201cangiographically silent\u201d intimal thickening. Circulation 1992, 85:979\u2013987.","journal-title":"Circulation"},{"key":"49_CR77","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1161\/01.CIR.92.12.3445","volume":"92","author":"PR Rickenbacher","year":"1995","unstructured":"Rickenbacher PR, Pinto FJ, Lewis NP, et al.: Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation. Circulation 1995, 92:3445\u20133452.","journal-title":"Circulation"},{"key":"49_CR78","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0735-1097(94)00323-I","volume":"25","author":"PR Rickenbacher","year":"1995","unstructured":"Rickenbacher PR, Pinto FJ, Chenzbraun A, et al.: Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995, 25:171\u2013177.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR79","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1097\/00019501-199608000-00006","volume":"7","author":"RH Mohiaddin","year":"1996","unstructured":"Mohiaddin RH, Bogren HG, Lazim F, et al.: Magnetic resonance coronary angiography in heart transplant recipients. Coron Artery Dis 1996, 7:591\u2013597.","journal-title":"Coron Artery Dis"},{"key":"49_CR80","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0735-1097(03)00924-0","volume":"42","author":"OM Muehling","year":"2003","unstructured":"Muehling OM, Wilke NM, Panse P, et al.: Reduced myocardial perfusion reserve and transmural perfusion gradient in heart transplant arteriopathy assessed by magnetic resonance imaging. J Am Coll Cardiol 2003, 42:1054\u20131060.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR81","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1161\/01.CIR.101.17.2078","volume":"101","author":"RD Knollmann","year":"2000","unstructured":"Knollmann RD, Bocksch W, Spiegelsberger S, et al.: Electron bean computed tomography in the assessment of coronary artery disease after heart transplantation. Circulation 2000, 101:2078\u20132082.","journal-title":"Circulation"},{"key":"49_CR82","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/euhj.1998.1270","volume":"20","author":"PF Ludman","year":"1999","unstructured":"Ludman PF, Lazem F, Barbir M, et al.: Incidence and clinical relevance of coronary calcification detection by electron beam computed tomography in heart transplant recipients. Eur Heart J 1999, 20:303\u2013308.","journal-title":"Eur Heart J"},{"key":"49_CR83","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.amjcard.2004.03.064","volume":"93","author":"NB Ratliff","year":"2004","unstructured":"Ratliff NB, Jorgensen CR, Gobel FL, et al.: Lack of usefulness of electron beam computed tomography for detecting coronary allograft vasculopathy. Am J Cardiol 2004, 93:202\u2013206.","journal-title":"Am J Cardiol"},{"key":"49_CR84","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1097\/01.TP.0000112437.07994.46","volume":"77","author":"KT Bae","year":"2004","unstructured":"Bae KT, Hong C, Takahashi N, et al.: Multi-detector ro computed tomographic angiography in pediatric heart transplant recipients: Initial observations. Transplantation 2004, 77:599\u2013602.","journal-title":"Transplantation"},{"key":"49_CR85","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0002-9149(96)90391-4","volume":"78","author":"CH Spes","year":"1996","unstructured":"Spes CH, Mudra H, Schnaack SD, et al.: Dobutamine stress echocardiography for noninvasive diagnosis of cardiac allograft vasculopathy: a comparison with angiography and intravascular ultrasound. Am J Cardiol 1996, 78:168\u2013174.","journal-title":"Am J Cardiol"},{"key":"49_CR86","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.100.5.509","volume":"100","author":"CH Spes","year":"1999","unstructured":"Spes CH, Klauss V, Mudra H, et al.: Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. Circulation 1999, 100:509\u2013515.","journal-title":"Circulation"},{"key":"49_CR87","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.healun.2003.09.007","volume":"23","author":"F Bacal","year":"2004","unstructured":"Bacal F, Moreira L, Souza G, et al.: Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 2004, 23:1238\u20131244.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR88","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1056\/NEJM199509073331003","volume":"333","author":"JA Kobashigawa","year":"1995","unstructured":"Kobashigawa JA, Katznelson S, Laks H, et al.: Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 1995, 333:621\u2013627.","journal-title":"N Engl J Med"},{"key":"49_CR89","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/01.CIR.96.5.1398","volume":"96","author":"K Wenke","year":"1997","unstructured":"Wenke K, Meiser B, Thiery J, et al.: Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial. Circulation 1997, 96:1398\u20131402.","journal-title":"Circulation"},{"key":"49_CR90","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/01.CIR.0000043241.32523.EE","volume":"107","author":"K Wenke","year":"2003","unstructured":"Wenke K, Meiser B, Thiery J, et al.: Simvastatin initiated early after heart transplantation. 8 year prospective experience. Circulation 2003, 107:93\u201397.","journal-title":"Circulation"},{"key":"49_CR91","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0735-1097(02)02340-9","volume":"40","author":"MR Mehra","year":"2002","unstructured":"Mehra MR, Uber PA, Vivekananthan K, et al.: Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection. J Am Coll Cardiol 2002, 40:1609\u20131614.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR92","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S1053-2498(00)00077-2","volume":"19","author":"A Keogh","year":"2000","unstructured":"Keogh A, Macdonald P, Kaan A, et al.: Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant 2000, 19:529\u2013537.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR93","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.amjcard.2004.09.035","volume":"95","author":"AH Wu","year":"2005","unstructured":"Wu AH, Ballantyne CM, Short BC, et al.: Statin use and risks of death or fatal rejection in the Heart Translant Lipid Registry. Am J Cardiol 2005, 95:367\u2013372.","journal-title":"Am J Cardiol"},{"key":"49_CR94","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","volume":"100","author":"HA Valantine","year":"1999","unstructured":"Valantine HA, Gao SZ, Menon SG, et al.: Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation 1999, 100:61\u201366.","journal-title":"Circulation"},{"key":"49_CR95","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1097\/00007890-200111270-00012","volume":"72","author":"HA Valantine","year":"2001","unstructured":"Valantine HA, Luikart H, Doyle R, et al.: Impact of cytomegalovirus hyperimmune globulin on outcome after cardiothoracic transplantation: a comparative study of combined prophylaxis with CMV hyperimmune globulin plus ganciclovir versus ganciclovir alone. Transplantation 2001, 72:1647\u20131652.","journal-title":"Transplantation"},{"issue":"Suppl 3A","key":"49_CR96","doi-asserted-by":"publisher","first-page":"171S","DOI":"10.1016\/S0041-1345(03)00229-X","volume":"35","author":"B Randovancevic","year":"2003","unstructured":"Randovancevic B, Vrtovec B: Sirolimus therapy in cardiac transplantation. Transplantation Proc 2003, 35 (Suppl 3A):171S-176S.","journal-title":"Transplantation Proc"},{"key":"49_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1161\/01.CIR.0000070421.38604.2B","volume":"108","author":"D Mancini","year":"2003","unstructured":"Mancini D, Pinney S, Burkhoff D, et al.: Use of rapamycin slows progression of cardiac transplantation vasculopathy. Circulation 2003, 108:48\u201353.","journal-title":"Circulation"},{"key":"49_CR98","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1161\/01.CIR.0000136812.90177.94","volume":"110","author":"A Keogh","year":"2004","unstructured":"Keogh A, Richardson M, Ruygrok P, et al.: Sirolimus in de novo heart transplant recipients reduces acute rejection and prevents coronary artery disease at 2 years: a randomized clinical trial. Circulation 2004, 110:2694\u20132700.","journal-title":"Circulation"},{"key":"49_CR99","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa022171","volume":"349","author":"HJ Eisen","year":"2003","unstructured":"Eisen HJ, Tuzcu EM, Dorent R, et al.: Everolimus for the prevention of allograft rejection and vasculopathy in cardiac transplant recipients. N Engl J Med 2003, 349:847\u2013858.","journal-title":"N Engl J Med"},{"key":"49_CR100","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/0735-1097(95)00124-I","volume":"26","author":"AA Halle","year":"1995","unstructured":"Halle AA 3rd, DiSciascio G, Massin EK, et al.: Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995, 26:120\u2013128.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR101","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1016\/j.jacc.2004.02.045","volume":"43","author":"RL Benza","year":"2004","unstructured":"Benza RL, Zoghbi GJ, Tallaj J, et al.: Palliation of allograft vasculopathy with transluminal angioplasty: a decade of experience. J Am Coll Cardiol 2004, 43:1973\u20131981.","journal-title":"J Am Coll Cardiol"},{"key":"49_CR102","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jtcvs.2004.09.031","volume":"129","author":"PW Fedak","year":"2005","unstructured":"Fedak PW, Rao V, Verma S, et al.: Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation. J Thorac Cardiovasc Surg 2005, 129:407\u2013415.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"49_CR103","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.RES.86.9.982","volume":"86","author":"CY Wang","year":"2000","unstructured":"Wang CY, Aronson I, Takuma S, et al.: cAMP pulse during preservation inhibits the late development of cardiac isograft and allograft vasculopathy. Circ Res 2000, 86:982\u2013988.","journal-title":"Circ Res"},{"key":"49_CR104","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S1053-2498(00)00200-X","volume":"19","author":"A Iwata","year":"2000","unstructured":"Iwata A, Sai S, Moore M, et al.: Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase. J Heart Lung Transplant 2000, 19:1017\u20131028.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR105","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S1053-2498(00)00203-5","volume":"20","author":"FG School","year":"2001","unstructured":"School FG, Sen L, Drinkwater DC, et al.: Effects of human tissue plasminogen gene transfer on allograft coronary atherosclerosis. J Heart Lung Transplant 2001, 20:322\u2013329.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR106","first-page":"1141","volume":"16","author":"J Suzuki","year":"1997","unstructured":"Suzuki J, Isobe M, Yamazaki S, et al.: Inhibition of accelerated coronary atherosclerosis with short-term blockade of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 in a heterotopic murine model of heart transplantation. J Heart Lung Transplant 1997, 16:1141\u20131148.","journal-title":"J Heart Lung Transplant"},{"key":"49_CR107","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/00007890-199308000-00039","volume":"56","author":"CG Orosz","year":"1993","unstructured":"Orosz CG, Ohye RG, Pelletier RP, et al.: Treatment with anti-vascular cell adhesion molecule 1 monoclonal antibody induces long-term murine cardiac allograft acceptance. Transplantation 1993, 56:453\u2013460.","journal-title":"Transplantation"},{"key":"49_CR108","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1097\/00007890-199405000-00014","volume":"57","author":"PS Russell","year":"1994","unstructured":"Russell PS, Chase CM, Winn HJ, et al.: Coronary atherosclerosis in transplanted mouse hearts. III. Effects of recipient treatment with a monoclonal antibody to interferon-gamma. Transplantation 1994, 57:1367\u20131371.","journal-title":"Transplantation"},{"key":"49_CR109","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1161\/01.CIR.0000013022.11250.30","volume":"105","author":"CY Wang","year":"2002","unstructured":"Wang CY, Mazer SP, Minamoto K, et al.: Suppression of murine cardiac allograft arteriopathy by long term blockade of CD40-CD154 interactions. Circulation 2002, 105:1609\u20131614.","journal-title":"Circulation"},{"key":"49_CR110","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1161\/01.ATV.0000141045.49616.6f","volume":"24","author":"A Saiura","year":"2004","unstructured":"Saiura A, Sata M, Hiasa K, et al.: Antimonocyte chemoattractant protein-1 gene therapy attenuates graft vasculopathy. Arterioscler Thromb Vasc Biol 2004, 24:1886\u20131890.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"49_CR111","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1161\/01.CIR.0000143052.45956.71","volume":"110","author":"K Yamoura","year":"2004","unstructured":"Yamoura K, Ito K, Tsukioka K, et al.: Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy. Circulation 2004, 110:1650\u20131657.","journal-title":"Circulation"},{"key":"49_CR112","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1161\/CIRCULATIONAHA.104.516708","volume":"112","author":"T El-Sawy","year":"2005","unstructured":"El-Sawy T, Belperio JA, Strieter RM, et al.: Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection. Circulation 2005, 112:320\u2013331.","journal-title":"Circulation"},{"key":"49_CR113","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/01.TP.0000147199.60464.F9","volume":"79","author":"AI Nykanen","year":"2005","unstructured":"Nykanen AI, Krebs R, Tikkanen JM, et al.: Combined vascular endothelial growth factor and platelet-derived growth factor inhibition in rat cardiac allografts: beneficial effects on inflammation and smooth muscle cell proliferation. Transplantation 2005, 79:182\u2013189.","journal-title":"Transplantation"},{"key":"49_CR114","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/01.CIR.0000054623.35669.3F","volume":"107","author":"AI Nykanen","year":"2003","unstructured":"Nykanen AI, Krebs R, Saaristo A, et al.: Angiopoietin-1 protects against the development of cardiac allograft arteriosclerosis. Circulation 2003, 107:1308\u20131314.","journal-title":"Circulation"},{"key":"49_CR115","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nm0897-900","volume":"3","author":"M Isobe","year":"1997","unstructured":"Isobe M, Suzuki JI, Morishita R, et al.: Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Nat Med 1997, 3:900\u2013903.","journal-title":"Nat Med"},{"key":"49_CR116","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1161\/01.RES.87.11.1063","volume":"87","author":"M Kawauchi","year":"2000","unstructured":"Kawauchi M, Suzuki J, Morishita R, et al.: Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Circ Res 2000, 87:1063\u20131068.","journal-title":"Circ Res"},{"key":"49_CR117","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0008-6363(02)00592-8","volume":"56","author":"K Tsukioka","year":"2002","unstructured":"Tsukioka K, Suzuki J, Fujimori M, et al.: Expression of matrix metalloproteinases in cardiac allograft vasculopathy and its attenuation by anti MMP-2 ribozyme gene transfection. Cardiovasc Res 2002, 56:472\u2013478.","journal-title":"Cardiovasc Res"}],"container-title":["Current Atherosclerosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-006-0049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11883-006-0049-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-006-0049-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11883-006-0049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:27:50Z","timestamp":1744147670000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11883-006-0049-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":117,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1007\/s11883-006-0049-1","relation":{},"ISSN":["1523-3804","1534-6242"],"issn-type":[{"type":"print","value":"1523-3804"},{"type":"electronic","value":"1534-6242"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}